StockSays

AXP−0.12moodBE−0.72moodBAH−0.06moodARLP±5.7%earnings Oct 26RHI+0.59moodFIX−0.24moodSLB+0.67moodBOH±5.9%earnings Oct 26RCBC0.00moodRCIAF+0.15moodALV−0.08moodDEA±6.3%earnings Oct 26AXP−0.12moodBE−0.72moodBAH−0.06moodARLP±5.7%earnings Oct 26RHI+0.59moodFIX−0.24moodSLB+0.67moodBOH±5.9%earnings Oct 26RCBC0.00moodRCIAF+0.15moodALV−0.08moodDEA±6.3%earnings Oct 26

FIX−0.24moodSLB+0.67moodBOH±5.9%earnings Oct 26RCBC0.00moodRCIAF+0.15moodALV−0.08moodDEA±6.3%earnings Oct 26GMAB+0.53moodMBLY−0.62moodDASH−0.33moodHBT±5.5%earnings Oct 26FLG−0.48moodFIX−0.24moodSLB+0.67moodBOH±5.9%earnings Oct 26RCBC0.00moodRCIAF+0.15moodALV−0.08moodDEA±6.3%earnings Oct 26GMAB+0.53moodMBLY−0.62moodDASH−0.33moodHBT±5.5%earnings Oct 26FLG−0.48mood

ALV−0.08moodDEA±6.3%earnings Oct 26GMAB+0.53moodMBLY−0.62moodDASH−0.33moodHBT±5.5%earnings Oct 26FLG−0.48moodJBLU−0.58moodGNTX−0.11moodMED±19.2%earnings Oct 26HTH−0.39moodMRNA−0.62moodALV−0.08moodDEA±6.3%earnings Oct 26GMAB+0.53moodMBLY−0.62moodDASH−0.33moodHBT±5.5%earnings Oct 26FLG−0.48moodJBLU−0.58moodGNTX−0.11moodMED±19.2%earnings Oct 26HTH−0.39moodMRNA−0.62mood

HBT±5.5%earnings Oct 26FLG−0.48moodJBLU−0.58moodGNTX−0.11moodMED±19.2%earnings Oct 26HTH−0.39moodMRNA−0.62moodPURR+0.67moodMNSB±4.8%earnings Oct 26CORT−1.00moodSGML+0.46moodMAIN−0.65moodHBT±5.5%earnings Oct 26FLG−0.48moodJBLU−0.58moodGNTX−0.11moodMED±19.2%earnings Oct 26HTH−0.39moodMRNA−0.62moodPURR+0.67moodMNSB±4.8%earnings Oct 26CORT−1.00moodSGML+0.46moodMAIN−0.65mood

HTH−0.39moodMRNA−0.62moodPURR+0.67moodMNSB±4.8%earnings Oct 26CORT−1.00moodSGML+0.46moodMAIN−0.65moodABG±11.5%earnings Oct 27ELME−1.00moodCRDO−0.29moodCPIX−1.00moodACU±9.7%earnings Oct 27HTH−0.39moodMRNA−0.62moodPURR+0.67moodMNSB±4.8%earnings Oct 26CORT−1.00moodSGML+0.46moodMAIN−0.65moodABG±11.5%earnings Oct 27ELME−1.00moodCRDO−0.29moodCPIX−1.00moodACU±9.7%earnings Oct 27

SGML+0.46moodMAIN−0.65moodABG±11.5%earnings Oct 27ELME−1.00moodCRDO−0.29moodCPIX−1.00moodACU±9.7%earnings Oct 27DECK−0.24moodNCLH−0.47moodET+0.58moodAEYE±25.9%earnings Oct 27FHB−0.25moodSGML+0.46moodMAIN−0.65moodABG±11.5%earnings Oct 27ELME−1.00moodCRDO−0.29moodCPIX−1.00moodACU±9.7%earnings Oct 27DECK−0.24moodNCLH−0.47moodET+0.58moodAEYE±25.9%earnings Oct 27FHB−0.25mood

CPIX−1.00moodACU±9.7%earnings Oct 27DECK−0.24moodNCLH−0.47moodET+0.58moodAEYE±25.9%earnings Oct 27FHB−0.25moodTMUS−0.46moodSLM−0.24moodAGYS±17.9%earnings Oct 27ONC+0.67moodBMY−0.32moodCPIX−1.00moodACU±9.7%earnings Oct 27DECK−0.24moodNCLH−0.47moodET+0.58moodAEYE±25.9%earnings Oct 27FHB−0.25moodTMUS−0.46moodSLM−0.24moodAGYS±17.9%earnings Oct 27ONC+0.67moodBMY−0.32mood

AEYE±25.9%earnings Oct 27FHB−0.25moodTMUS−0.46moodSLM−0.24moodAGYS±17.9%earnings Oct 27ONC+0.67moodBMY−0.32moodIOVA+1.00moodAMKR±20.6%earnings Oct 27T−0.45moodWSFS+0.51moodRCI+0.22moodAEYE±25.9%earnings Oct 27FHB−0.25moodTMUS−0.46moodSLM−0.24moodAGYS±17.9%earnings Oct 27ONC+0.67moodBMY−0.32moodIOVA+1.00moodAMKR±20.6%earnings Oct 27T−0.45moodWSFS+0.51moodRCI+0.22mood

ONC+0.67moodBMY−0.32moodIOVA+1.00moodAMKR±20.6%earnings Oct 27T−0.45moodWSFS+0.51moodRCI+0.22moodARE±16.1%earnings Oct 27LEVI−1.00moodABR−0.33moodSNNUF−0.82moodATI±13.6%earnings Oct 27ONC+0.67moodBMY−0.32moodIOVA+1.00moodAMKR±20.6%earnings Oct 27T−0.45moodWSFS+0.51moodRCI+0.22moodARE±16.1%earnings Oct 27LEVI−1.00moodABR−0.33moodSNNUF−0.82moodATI±13.6%earnings Oct 27

NMRA

← Markets

NMRANeumora Therapeutics, Inc.

Discussion

Nothing said here yet.

to join the conversation.


Aurora Daljit SinghSee Remarks	Sell	21,055	$33.6K	Fri, Aug 21
Aurora Daljit SinghSee Remarks	Sell	20,553	$32.8K	Fri, Aug 21
Aurora Daljit SinghSee Remarks	Sell	67,741	$102.6K	Thu, Aug 20
Aurora Daljit SinghSee Remarks	Sell	66,711	$101.0K	Thu, Aug 20
Aurora Daljit SinghSee Remarks	Sell	31,000	$51.0K	Wed, Aug 19
Aurora Daljit SinghSee Remarks	Sell	30,918	$50.9K	Wed, Aug 19
Aurora Daljit SinghSee Remarks	Sell	34,987	$55.5K	Tue, Aug 18
Aurora Daljit SinghSee Remarks	Sell	34,162	$54.1K	Tue, Aug 18
Aurora Daljit SinghSee Remarks	Sell	57,670	$86.8K	Mon, Aug 17
Aurora Daljit SinghSee Remarks	Sell	55,016	$82.8K	Mon, Aug 17
Aurora Daljit SinghSee Remarks	Sell	34,020	$50.5K	Mon, Aug 17

Fri, Sep 18
11:46 AMYahoo
Biotech Options Buzz: UTHR, NMRA, EWTX
UTHR, NMRA, and EWTX are drawing attention from options bears
Fri, Aug 14
7:00 AMYahoo
Neumora Therapeutics Reports Second Quarter 2026 Financial Results and Provides Business Update
Favorable pre-clinical data reported for NMRA-215 with plan to submit IND in fourth quarter of 2026 and initiate Phase 1 study by end of 2026 Progressing NMRA-511 in Alzheimer’s disease (AD) agitation and NMRA-898 in schizophrenia with clinical data expected in fourth quarter of 2026 and second half of 2026, respectively Joshua Pinto, Ph.D., appointed chief executive officer and member of the Board of Directors Paul L.
Mon, Jul 27
7:00 AMYahoo
Neumora Therapeutics Reports Favorable NMRA-215 Toxicology Results with Planned Clinical Advancement in 2026
Company plans to submit an IND in the fourth quarter of 2026 and to initiate Phase 1 study by the end of 2026WATERTOWN, Mass., July 27, 2026 (GLOBE NEWSWIRE) -- Neumora Therapeutics, Inc.
Sat, Jul 11
11:08 AMYahoo
Neumora Therapeutics (NMRA) Stock Sees Fair Value Falls After Navacaprant Discontinuation
Neumora Therapeutics is back in focus after analysts cut their fair value estimate from US$8.91 to US$6.53 per share, a reduction of about 27% that resets expectations around the stock.
Tue, Jul 7
1:53 AMYahoo
Why Neumora Therapeutics, Inc. (NMRA) Is One of the Best Get Rich Quick Stocks to Buy
Neumora Therapeutics, Inc. (NASDAQ:NMRA) is among the best get rich quick stocks to buy right now. On June 18, Mizuho lowered the price target on Neumora Therapeutics, Inc. (NASDAQ:NMRA) to $4, down from $6.